Ilyang Pharmaceutical Co Ltd (007575) — Working Capital to Net Assets Ratio
Ilyang Pharmaceutical Co Ltd (007575) has a Working Capital to Net Assets ratio of -8.5% as of June 2025. Working capital of ₩-20.45 Billion (current assets of ₩139.81 Billion minus current liabilities of ₩160.26 Billion) is measured against net assets of ₩239.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Ilyang Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ilyang Pharmaceutical Co Ltd Working Capital to Net Assets (2014–2024)
This chart shows how Ilyang Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of June 2025, the ratio stands at -8.5%, reflecting working capital of ₩-20.45 Billion against net assets of ₩239.41 Billion KRW. See Ilyang Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Ilyang Pharmaceutical Co Ltd (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ilyang Pharmaceutical Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Ilyang Pharmaceutical Co Ltd (007575) market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -13.1% | ₩-31.53 Billion | ₩241.58 Billion | ₩125.37 Billion | ₩156.90 Billion | ▼ -0.3 pp |
| 2023 | -12.7% | ₩-24.99 Billion | ₩196.41 Billion | ₩114.20 Billion | ₩139.19 Billion | ▼ -17.5 pp |
| 2022 | 4.8% | ₩13.87 Billion | ₩291.85 Billion | ₩200.73 Billion | ₩186.86 Billion | ▲ +2.8 pp |
| 2021 | 2.0% | ₩5.35 Billion | ₩271.76 Billion | ₩203.56 Billion | ₩198.21 Billion | ▲ +8.0 pp |
| 2020 | -6.0% | ₩-14.65 Billion | ₩244.92 Billion | ₩162.50 Billion | ₩177.15 Billion | ▼ -2.0 pp |
| 2019 | -4.0% | ₩-8.92 Billion | ₩222.74 Billion | ₩171.41 Billion | ₩180.33 Billion | ▲ +6.6 pp |
| 2018 | -10.6% | ₩-22.31 Billion | ₩209.88 Billion | ₩161.38 Billion | ₩183.69 Billion | ▲ +8.6 pp |
| 2017 | -19.2% | ₩-40.57 Billion | ₩210.98 Billion | ₩166.14 Billion | ₩206.71 Billion | ▼ -3.2 pp |
| 2016 | -16.0% | ₩-34.76 Billion | ₩217.35 Billion | ₩147.67 Billion | ₩182.43 Billion | ▼ -1.2 pp |
| 2015 | -14.8% | ₩-31.27 Billion | ₩211.00 Billion | ₩146.84 Billion | ₩178.11 Billion | ▼ -9.2 pp |
| 2014 | -5.6% | ₩-10.35 Billion | ₩183.46 Billion | ₩158.52 Billion | ₩168.87 Billion | — |